Layer, Chiang, et al. Genome Biology
Helicos Installs Two Instruments in Q2, Seeks New Funding Sources as $5M of Cash Remain
The company said in a document filed recently with the Securities and Exchange Commission that its current cash and expected revenue, coupled with cost-cutting measures, will enable it to fund its operations into the first quarter of 2010 while it seeks new funding sources.
New to GenomeWeb? Register here quickly.